Compare PCAR & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCAR | COR |
|---|---|---|
| Founded | 1905 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.4B | 62.0B |
| IPO Year | 2010 | 2001 |
| Metric | PCAR | COR |
|---|---|---|
| Price | $132.92 | $320.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $118.11 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 3.5M | 1.4M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.30% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | 2.57 | ★ 15.21 |
| Revenue | $28,444,800,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $2.75 | $8.89 |
| Revenue Next Year | $9.41 | $6.75 |
| P/E Ratio | $51.39 | ★ $21.37 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $92.25 | $244.82 |
| 52 Week High | $139.24 | $377.54 |
| Indicator | PCAR | COR |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | 67.08 |
| Support Level | $109.33 | $297.37 |
| Resistance Level | $139.24 | $326.95 |
| Average True Range (ATR) | 4.11 | 7.57 |
| MACD | -0.18 | 0.23 |
| Stochastic Oscillator | 51.96 | 93.07 |
Paccar is a leading manufacturer of medium- and heavy-duty trucks under the premium nameplates Kenworth and Peterbilt, which are primarily sold in the Americas and Australia, and DAF, which primarily services Europe and South America. The trucks segment (74% sales) goes to market through a network of 2,200 independent dealers. Paccar maintains an internal finance subsidiary that provides retail and wholesale financing for customers and dealers (6% sales). In recent years, Paccar has aggressively expanded its parts business (20% of sales), including engines, axles, and transmissions for its own truck brands as well as independent producers. The company commands 30% of the Class 8 market share in North America and 15% of the heavy-duty market share in Europe.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.